To explore the clinical significance of IRF4-mediated differentiation of PMN-MDSCs, peripheral blood samples from patients with liver cancer (HCC) were collected, and peripheral blood samples from nontumor patients with liver fibrosis served as controls. This evidence concerns the gene IRF4 and Hepatic fibrosis.